Doula Combined Latent Phrase Epidural Analgesia in Primiparous Women

NCT ID: NCT00664118

Last Updated: 2009-05-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

500 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-04-30

Study Completion Date

2009-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Accumulating evidence indicated that neuraxial analgesia in the latent phase of the first stage of labor would be an effective and safe health care procedure for nulliparas. Doulas, women with labor experience trained for parturients, is a new way to alleviate the psychological stress from the laboring pain. Previous data in our study showed that doula accompany is a good method in shortening the progress of labor used in the active phrase of the first stage of labor, and decreasing the rate of cesarean delivery. Investigators hypothesized that doula combined neuraxial (epidural) analgesia in the latent phrase would be a superior means for effective pain relief, decreased rate of cesarean section, and shortened duration of labor.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Labor Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Doula combined epidural analgesia in the latent phase of first stage of labor

Group Type ACTIVE_COMPARATOR

Doula combined analgesia

Intervention Type PROCEDURE

Doula combined epidural analgesia in the latent phase of first stage of labor in primiparas

2

Epidural analgesia in the latent phase of the first stage of labor without doula accompany

Group Type SHAM_COMPARATOR

Analgesia without doula

Intervention Type PROCEDURE

Epidural analgesia in the latent phase of first stage of labor without doula accompany in primiparas

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Doula combined analgesia

Doula combined epidural analgesia in the latent phase of first stage of labor in primiparas

Intervention Type PROCEDURE

Analgesia without doula

Epidural analgesia in the latent phase of first stage of labor without doula accompany in primiparas

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Nulliparous women
* \> 18 years and \< 45 years
* Spontaneous labor
* Analgesia request

Exclusion Criteria

* Allergy to opioids, a history of the use of centrally-acting drugs of any sort, chronic pain and psychiatric diseases records
* Participants younger than 18 years or older than 45 years
* Those who were not willing to or could not finish the whole study at any time
* Using or used in the past 14 days of the monoamine oxidase inhibitors;
* Alcohol addictive or narcotic dependent patients were excluded for their influence on the analgesic efficacy of the epidural analgesics
* Subjects with a nonvertex presentation or scheduled induction of labor
* Cervical dilation was 4.0 cm or greater before performing epidural puncture and catheterization
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

HRSA/Maternal and Child Health Bureau

FED

Sponsor Role collaborator

Nanjing Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nanjing Medical University

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

XiaoFeng Shen, MD

Role: STUDY_DIRECTOR

Nanjing Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nanjing Maternal and Child Health Care Hospital

Nanjing, Jiangsu, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NMUC-08022

Identifier Type: -

Identifier Source: secondary_id

NMCHCH-0121-236

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pocket Warming of Epidural Medication
NCT02912078 ACTIVE_NOT_RECRUITING NA